CXR Stock

Impending recapitalization and increasing competition from generics means there’s little value in ... Read More

Laurentian Bank Securities analyst Joseph Walewicz says Concordia International (TSX:CXR) is a stock... Read More

Just a few days after the resignation of its CEO, a newly announced investigation into pharmaceutica... Read More

It makes sense that Concordia International (Concordia International Stock Quote, Chart, News: TSX:C... Read More

A proposed debt offering has taken Laurentian Bank Securities analyst Joseph Walewicz by surprise an... Read More

Proposed legislation from the United Kingdom has Laurentian Bank Securities analyst Joseph Walewicz ... Read More

A quarter from Concordia Healthcare (Concordia Healthcare Stock Quote, Chart, News: TSX:CXR, Nasdaq:... Read More

The acquisition of AMCo has diversifed Concordia Healthcare’s (Concordia Healthcare Stock Quot... Read More

New guidance numbers from Concordia Healthcare (Condordia Healthcare Stock Quote, Chart, News: TSX:C... Read More

The recent negative sentiment towards Valeant Pharmaceuticals is unfairly spilling over to Concordia... Read More

Shares of Concordia Healthcare (TSX:CXR) are under pressure today after the company announced it had... Read More

A board and management shakeup at Concordia Healthcare (Concordia Healthcare Stock Quote, Chart, New... Read More

Laurentian Bank Securities analyst Joseph Walewicz likes Concordia Healthcare’s (Concordia Hea... Read More

It was a wild year for Life Sciences stocks on the TSX, with exciting new entrants and several stock... Read More

Recent news that Halifax-based Immunovaccine (TSXV:IMV) was pulling its proposed public financing du... Read More

>Concordia Healthcare (TSX:CXR) today announced that it would acquire Donnatal® for US$200 million ... Read More